In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines
- 19 December 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 39 (3) , 447-457
Abstract
Ghrelin gene generates several variants that regulate multiple pathophysiological functions, including tumor-related processes. In1-ghrelin is a splicing variant that was previously shown to be overexpressed in breast cancer (BCa), where it correlated with proliferation markers; however, its possible association with clinical outcome of BCa patients and underlying mechanisms are still unknown. To address this issue, expression levels and clinical associations of In1-ghrelin were analyzed in a cohort of 117 BCa samples. Additionally, a battery of cellular and molecular assays was implemented using two BCa cell lines (MCF-7 and MDA-MB-231), wherein the role of In1-ghrelin on proliferation, migration, dedifferentiation and signaling pathways was explored. The results generated revealed that high expression of In1-ghrelin in BCa samples was associated with lymph node metastasis and reduced disease-free survival. Indeed, In1-ghrelin overexpression stimulated proliferation and migration in MCF-7 and MDA-MB-231 cells. Similar results were found by treating MDA-MB-231 and MCF-7 with In1-ghrelin-derived peptides. Conversely, In1-ghrelin silencing decreased proliferation and migration capacities of MDA-MB-231. Furthermore, In1-ghrelin (but not ghrelin) overexpression increased the capacity to form mammospheres in both cell lines. These effects could be associated with activation of MAPK-ERK, Jag1/Notch, Wnt/beta-catenin and/or TGF-beta 1 pathways. Altogether, our data indicate that In1-ghrelin could play relevant functional roles in the regulation of BCa development and progression and may provide insights to identify novel biomarkers and new therapeutic approaches for this pathology.Keywords
Funding Information
- Instituto de Salud Carlos III
This publication has 42 references indexed in Scilit:
- Genetic heterogeneity in breast cancer: the road to personalized medicine?BMC Medicine, 2013
- The 'alternative' EMT switchBreast Cancer Research, 2011
- A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological RelevancePLOS ONE, 2011
- Lysyl oxidase‐like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal‐like breast carcinomasEMBO Molecular Medicine, 2011
- The Role of Breast Cancer Stem Cells in Metastasis and Therapeutic ImplicationsThe American Journal of Pathology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Targeting Notch to Target Cancer Stem CellsClinical Cancer Research, 2010
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in AcromegalyThe Journal of Clinical Endocrinology & Metabolism, 2009
- Signaling cross-talk between TGF-β/BMP and other pathwaysCell Research, 2008
- The Hallmarks of CancerCell, 2000